BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23484396)

  • 1. [Efficacy and safety of vaccines against human papillomavirus (HPV)].
    Prygiel M; Janaszek-Seydlitz W
    Przegl Epidemiol; 2012; 66(4):657-65. PubMed ID: 23484396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Human papilloma virus (HPV) prophylactic vaccination: challenges for public health and implications for screening.
    Adams M; Jasani B; Fiander A
    Vaccine; 2007 Apr; 25(16):3007-13. PubMed ID: 17292517
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human Pappilomavirus (HPV) induced cancers and prevention by immunization.
    Khaliq SA; Shyum Naqvi SB; Fatima A
    Pak J Pharm Sci; 2012 Oct; 25(4):763-72. PubMed ID: 23009992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HPV vaccination: preventing cervical cancer].
    Simon P; Dupond I
    Rev Med Brux; 2006 Sep; 27(4):S338-40. PubMed ID: 17091900
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Human papillomavirus prophylactic vaccines: stakes and perspectives].
    Hantz S; Alain S; Denis F
    Gynecol Obstet Fertil; 2006; 34(7-8):647-55. PubMed ID: 16807045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Preventive and therapeutic HPV vaccines.
    Monie A; Hung CF; Wu TC
    Curr Opin Investig Drugs; 2007 Dec; 8(12):1038-50. PubMed ID: 18058574
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Developments in HPV vaccination].
    de Melker H; Kenter G; van Rossum T; Conyn-van Spaendonck M
    Ned Tijdschr Geneeskd; 2012; 156(47):A5410. PubMed ID: 23171565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vaccination against human papillomavirus. Implementation and efficacy against cervical cancer control].
    Bégué P; Henrion R; Blanc B; Girard M; Sancho-Garnier H
    Bull Acad Natl Med; 2007 Dec; 191(9):1805-16; discussion 1816-7. PubMed ID: 18663976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical perspectives on the role of the human papillomavirus vaccine in the prevention of cancer.
    Julius JM; Ramondeta L; Tipton KA; Lal LS; Schneider K; Smith JA
    Pharmacotherapy; 2011 Mar; 31(3):280-97. PubMed ID: 21361739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Human papillomavirus vaccines].
    Brun JL
    J Gynecol Obstet Biol Reprod (Paris); 2008 Feb; 37 Suppl 1():S155-66. PubMed ID: 18187268
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Vaccination against human papillomavirus for the prevention of cervical cancer].
    Quint WG; ter Harmsel WA; van Doorn LJ
    Ned Tijdschr Geneeskd; 2006 Jun; 150(25):1380-4. PubMed ID: 16841585
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The clinical benefit and cost-effectiveness of human papillomavirus vaccination for adult women in the Netherlands.
    Bogaards JA; Coupé VM; Meijer CJ; Berkhof J
    Vaccine; 2011 Nov; 29(48):8929-36. PubMed ID: 21945961
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Acceptability of vaccination against human papillomavirus (HPV) by pediatricians, mothers and young women in Ho Chi Minh City, Vietnam].
    Phan DP; Pham QT; Strobel M; Tran DS; Tran TL; Buisson Y
    Rev Epidemiol Sante Publique; 2012 Dec; 60(6):437-46. PubMed ID: 23137871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of human papillomavirus infections and associated diseases by vaccination: a new hope for global public health.
    Harper DM
    Public Health Genomics; 2009; 12(5-6):319-30. PubMed ID: 19684444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human papillomavirus, cervical cancer, and the vaccines.
    Tovar JM; Bazaldua OV; Vargas L; Reile E
    Postgrad Med; 2008 Jul; 120(2):79-84. PubMed ID: 18654072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Benefits of vaccinating young adult women with a prophylactic quadrivalent human papillomavirus (types 6, 11, 16 and 18) vaccine.
    Monsonego J; Cortes J; Greppe C; Hampl M; Joura E; Singer A
    Vaccine; 2010 Nov; 28(51):8065-72. PubMed ID: 20971114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Vaccines against human papillomavirus and cervical cancer: promises and challenges.
    Mahdavi A; Monk BJ
    Oncologist; 2005 Aug; 10(7):528-38. PubMed ID: 16079320
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Impact of vaccination against oncogenic human papillomavirus on the incidence and mortality of cervical cancer in Germany].
    Schneider A; Schwarz TF; Hammerschmidt T; Siebert U
    Med Klin (Munich); 2007 Jul; 102(7):515-23. PubMed ID: 17634869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vaccination against human papillomavirus.
    BMJ Group
    Drug Ther Bull; 2008 Dec; 46(12):89-93. PubMed ID: 19056700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human papillomavirus vaccine: widening the scope for cancer prevention.
    No JH; Kim MK; Jeon YT; Kim YB; Song YS
    Mol Carcinog; 2011 Apr; 50(4):244-53. PubMed ID: 21465574
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.